annual total liabilities:
$28.04M+$7.97M(+39.72%)Summary
- As of today (May 29, 2025), VKTX annual total liabilities is $28.04 million, with the most recent change of +$7.97 million (+39.72%) on December 31, 2024.
- During the last 3 years, VKTX annual total liabilities has risen by +$19.27 million (+219.47%).
- VKTX annual total liabilities is now at all-time high.
Performance
VKTX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$20.07M-$7.97M(-28.41%)Summary
- As of today (May 29, 2025), VKTX quarterly total liabilities is $20.07 million, with the most recent change of -$7.97 million (-28.41%) on March 31, 2025.
- Over the past year, VKTX quarterly total liabilities has dropped by -$13.55 million (-40.30%).
- VKTX quarterly total liabilities is now -40.30% below its all-time high of $33.63 million, reached on March 31, 2024.
Performance
VKTX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VKTX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.7% | -40.3% |
| 3 y3 years | +219.5% | +57.4% |
| 5 y5 years | +292.9% | +127.6% |
VKTX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +219.5% | -40.3% | +57.4% |
| 5 y | 5-year | at high | +292.9% | -40.3% | +128.7% |
| alltime | all time | at high | >+9999.0% | -40.3% | +2557.5% |
VKTX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $20.07M(-28.4%) |
| Dec 2024 | $28.04M(+39.7%) | $28.04M(+6.1%) |
| Sep 2024 | - | $26.44M(+2.2%) |
| Jun 2024 | - | $25.86M(-23.1%) |
| Mar 2024 | - | $33.63M(+67.5%) |
| Dec 2023 | $20.07M(-13.5%) | $20.07M(+39.2%) |
| Sep 2023 | - | $14.42M(-1.1%) |
| Jun 2023 | - | $14.58M(-13.4%) |
| Mar 2023 | - | $16.83M(-27.5%) |
| Dec 2022 | $23.21M(+164.4%) | $23.21M(+50.7%) |
| Sep 2022 | - | $15.40M(-5.4%) |
| Jun 2022 | - | $16.28M(+27.6%) |
| Mar 2022 | - | $12.76M(+45.3%) |
| Dec 2021 | $8.78M(-27.8%) | $8.78M(-22.7%) |
| Sep 2021 | - | $11.35M(-11.8%) |
| Jun 2021 | - | $12.87M(-0.3%) |
| Mar 2021 | - | $12.92M(+6.2%) |
| Dec 2020 | $12.16M(+70.4%) | $12.16M(+23.7%) |
| Sep 2020 | - | $9.83M(+6.3%) |
| Jun 2020 | - | $9.25M(+4.9%) |
| Mar 2020 | - | $8.82M(+23.6%) |
| Dec 2019 | $7.14M | $7.14M(+7.6%) |
| Sep 2019 | - | $6.63M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $6.14M(+11.5%) |
| Mar 2019 | - | $5.51M(+20.7%) |
| Dec 2018 | $4.56M(-47.3%) | $4.56M(-3.8%) |
| Sep 2018 | - | $4.74M(+15.5%) |
| Jun 2018 | - | $4.11M(-35.2%) |
| Mar 2018 | - | $6.34M(-26.8%) |
| Dec 2017 | $8.66M(+33.3%) | $8.66M(-9.9%) |
| Sep 2017 | - | $9.61M(+24.3%) |
| Jun 2017 | - | $7.73M(+1.7%) |
| Mar 2017 | - | $7.61M(+17.2%) |
| Dec 2016 | $6.49M(-3.3%) | $6.49M(+6.5%) |
| Sep 2016 | - | $6.10M(+5.8%) |
| Jun 2016 | - | $5.76M(-17.5%) |
| Mar 2016 | - | $6.99M(+4.1%) |
| Dec 2015 | $6.71M(-73.3%) | $6.71M(+16.9%) |
| Sep 2015 | - | $5.74M(+17.8%) |
| Jun 2015 | - | $4.88M(-84.1%) |
| Mar 2015 | - | $30.61M(+21.6%) |
| Dec 2014 | $25.17M(+5740.3%) | $25.17M(-0.4%) |
| Jun 2014 | - | $25.27M(+3245.5%) |
| Mar 2014 | - | $755.40K |
| Dec 2013 | $431.00K(+308.9%) | - |
| Dec 2012 | $105.40K | - |
FAQ
- What is Viking Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual total liabilities year-on-year change?
- What is Viking Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly total liabilities year-on-year change?
What is Viking Therapeutics annual total liabilities?
The current annual total liabilities of VKTX is $28.04M
What is the all time high annual total liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total liabilities is $28.04M
What is Viking Therapeutics annual total liabilities year-on-year change?
Over the past year, VKTX annual total liabilities has changed by +$7.97M (+39.72%)
What is Viking Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VKTX is $20.07M
What is the all time high quarterly total liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total liabilities is $33.63M
What is Viking Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VKTX quarterly total liabilities has changed by -$13.55M (-40.30%)